Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report) shares traded down 6% during mid-day trading on Monday . The stock traded as low as $0.22 and last traded at $0.24. 1,922 shares were traded during mid-day trading, a decline of 72% from the average session volume of 6,928 shares. The stock had previously closed at $0.25.
Guided Therapeutics Trading Down 6.0%
The firm has a 50 day moving average price of $0.20 and a 200-day moving average price of $0.14. The firm has a market cap of $18.87 million, a price-to-earnings ratio of -4.70 and a beta of 0.11.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last issued its earnings results on Thursday, May 15th. The company reported ($0.01) earnings per share (EPS) for the quarter.
About Guided Therapeutics
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Further Reading
- Five stocks we like better than Guided Therapeutics
- 5 Top Rated Dividend Stocks to Consider
- Domino’s Delivers Another Discounted Entry for Income Investors
- Insider Buying Explained: What Investors Need to Know
- TSLA Earnings Week: Can Tesla Break Through $350?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Goldman, Morgan Stanley, & BofA: Diverging Paths After Earnings
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
